11.08.25 -- Best Of October: Using PATs For Real-Time Process Monitoring And More Top Reads

The moss Physcomitrium patens is especially good at producing glycoproteins. Established technology and prior knowledge are helping one company develop new therapies with it.

We follow the journey from master cell bank to large-scale anaerobic fermentation, stressing the unique needs for working with oxygen-sensitive, strictly anaerobic therapeutic microbes in a cGMP setting. 

In this segment from the Bioprocess Online Live event, “Aligning CMC And MSAT To Move PATs Out Of Pilot Mode,” our panelists respond to results from an audience poll. Audience members indicated they use PATs for real-time process monitoring more in upstream than in downstream. 

By prioritizing the management of Out of Expectation (OOX) results within your CDMO laboratory, learn how you can ensure product integrity, patient safety, and unwavering regulatory compliance.

One family managed to combine resources and people to get an investigational gene replacement therapy manufactured and approved by the FDA so their daughter could be dosed just 14 months from her diagnosis.

Examine how counting efficiency and resolution impact data interpretation in critical environments like cleanrooms and pharmaceuticals.